This is not meant to get into a partisan political discussion, but rather take a step back away from all of the talking points and shed light on to a real issue. If we really care about the less-fortunate, this should strike a nerve. When the donor is harder to track down post-donation, its much less riskier for these plasma centers to push the envelop on eligibility. Pharmaceutical mules?
https://www.propublica.org/article/...tm_campaign=newsletter_axiosvitals&stream=top
https://www.propublica.org/article/...tm_campaign=newsletter_axiosvitals&stream=top